Next Article in Journal
Investigation of the Impact of CYP3A5 Polymorphism on Drug–Drug Interaction between Tacrolimus and Schisantherin A/Schisandrin A Based on Physiologically-Based Pharmacokinetic Modeling
Next Article in Special Issue
Discovery and Optimization of Selective Inhibitors of Meprin α (Part I)
Previous Article in Journal
Synthesis, Biological Activity and In Silico Pharmacokinetic Prediction of a New 2-Thioxo-Imidazoldidin-4-One of Primaquine
Previous Article in Special Issue
Targeting Cartilage Degradation in Osteoarthritis

Article Versions Notes

Pharmaceuticals 2021, 14(3), 197;
Action Date Notes Link
article pdf uploaded. 27 February 2021 13:12 CET Version of Record
article xml file uploaded 13 March 2021 07:39 CET Original file -
article xml uploaded. 13 March 2021 07:39 CET Update
article pdf uploaded. 13 March 2021 07:39 CET Updated version of record
article html file updated 13 March 2021 07:41 CET Original file -
article html file updated 25 July 2022 05:24 CEST Update
Back to TopTop